2,800,000 Shares Smithtown Bancorp, Inc. Common Stock par value $0.01 per share Underwriting Agreement
2,800,000 Shares
Smithtown
Bancorp, Inc.
Common
Stock
par
value $0.01 per share
May 14,
2009
Sandler
X’Xxxxx & Partners, L.P.,
000 Xxxxx
Xxxxxx
0xx
Xxxxx
Xxx Xxxx,
Xxx Xxxx 00000
Ladies
and Gentlemen:
Smithtown
Bancorp, Inc., a New York corporation (the “Company”), proposes, subject to the
terms and conditions stated herein, to issue and sell to Sandler X’Xxxxx &
Partners, L.P. (the “Underwriter”) an aggregate of 2,800,000 shares (the “Firm
Shares”) and, at the election of the Underwriter, up to 200,000 additional
shares (the “Optional Shares”) of the common stock, par value $0.01 per share
(“Stock”), of the Company (the Firm Shares and the Optional Shares that the
Underwriter elects to purchase pursuant to Section 2 hereof being collectively
called the “Shares”).
The
Company has filed with the Securities and Exchange Commission (the “Commission”)
a registration statement on Form S-3 (No. 333-153897) covering the registration
of the Shares under the Securities Act of 1933, as amended (the “Act”),
including a related prospectus, which has become effective. The registration
statement (including the exhibits thereto and schedules thereto, if any) as
amended at the time it became effective, or, if a post-effective amendment has
been filed with respect thereto, as amended by such post-effective amendment at
the time of its effectiveness (including in each case the information (if any)
deemed to be part of such registration statement at the time of effectiveness
pursuant to Rule 430A under the Act), is hereinafter referred to as the
“Registration Statement.” The term “Effective Date” shall mean each
date that the Registration Statement and any post-effective amendment or
amendments thereto became or become effective. The term “Base
Prospectus” shall mean the prospectus referred to in Section 1(a)(i) hereof
contained in the Registration Statement at the Effective
Date. “Preliminary Prospectus” means any preliminary prospectus
supplement to the Base Prospectus used prior to the filing of the Prospectus,
together with the Base Prospectus; the term “Prospectus” means the final
prospectus supplement to the Base Prospectus first filed with the Commission
pursuant to Rule 424(b) under the Act, together with the Base
Prospectus. Any registration statement filed pursuant to Rule 462(b)
under the Act is herein referred to as the “Rule 462(b) Registration Statement,”
and after such filing the term “Registration Statement” shall include the Rule
462(b) Registration Statement.
Any
reference in this Agreement to the Registration Statement, any Preliminary
Prospectus or the Prospectus shall be deemed to refer to and include the
documents incorporated by reference therein pursuant to Item 12 of Form S-3
under the Act, as of the Effective Date or the date of such Preliminary
Prospectus or the Prospectus, as the case may be (it being understood that the
several specific references in this Agreement to documents incorporated by
reference in the Registration Statement or the Prospectus are for clarifying
purposes only and are not meant to limit the inclusiveness of any other
definition herein). For purposes of this Agreement, all references to
the Registration Statement, any Preliminary Prospectus, or the Prospectus or any
amendment or supplement to any of the foregoing shall be deemed to include the
copy filed with the Commission pursuant to its Electronic Data Gathering,
Analysis and Retrieval system (“XXXXX”).
All
references in this Agreement to financial statements and schedules and other
information which is “contained,” “included” or “stated” in the Registration
Statement, any Preliminary Prospectus or the Prospectus (or other references of
like import) shall be deemed to mean and include all such financial statements
and schedules and other information which is incorporated by reference in the
Registration Statement, any Preliminary Prospectus or the Prospectus, as the
case may be.
1. (a) The
Company represents and warrants to, and agrees with, the Underwriter
that:
(i)
The Company satisfies the registrant eligibility
requirements for the use of Form S-3 under the Act set forth in General
Instruction I.A to such Form and the transactions contemplated by this Agreement
satisfy the transaction eligibility requirements for the use of such Form set
forth in General Instruction I.B.1 to such Form; the Company has filed with the
Commission the Registration Statement on such Form, including a Base Prospectus,
for registration under the Act of the offering and sale of the Shares, and the
Company may have filed with the Commission one or more amendments to such
Registration Statement, each in the form previously delivered to
you. Such Registration Statement, as so amended, has been declared
effective by the Commission, and the Shares have been registered under the
Registration Statement in compliance with the requirements for the use of Form
S-3. Although the Base Prospectus may not include all the information
with respect to the Shares and the offering thereof required by the Act and the
rules and regulations of the Commission thereunder to be included in the
Prospectus, the Base Prospectus includes all such information required by the
Act and the rules and regulations of the Commission thereunder to be included
therein as of the Effective Date. The Company has complied to the
Commission’s satisfaction with all requests of the Commission for additional or
supplemental information; and no stop order suspending the effectiveness of the
Registration Statement has been issued and no proceeding for that purpose has
been initiated or, to the knowledge of the Company, threatened by the
Commission. After the execution of this Agreement, the Company will
file with the Commission pursuant to Rules 415 and 424(b)(2) or (5) a final
supplement to the Base Prospectus included in such Registration Statement
relating to the Shares and the offering thereof, with such information as is
required or permitted by the Act and as has been provided to and approved by the
Underwriter prior to the date hereof or, to the extent not completed at the date
hereof, containing only such specific additional information and other changes
(beyond that contained in the Base Prospectus and any Preliminary Prospectus) as
the Company has advised you, prior to the date hereof, will be included or made
therein. If the Company has elected to rely on Rule 462(b) and the
Rule 462(b) Registration Statement is not effective, (x) the Company will file a
Rule 462(b) Registration Statement in compliance with, and that is effective
upon filing pursuant to, Rule 462(b) and (y) the Company has given irrevocable
instructions for transmission of the applicable filing fee in connection with
the filing of the Rule 462(b) Registration Statement, in compliance with Rule
111 under the Act, or the Commission has received payment of such filing
fee.
(ii) No
order preventing or suspending the use of any Preliminary Prospectus has been
issued by the Commission, and each Preliminary Prospectus, at the time of filing
thereof, conformed in all material respects to the requirements of the Act and
the rules and regulations of the Commission thereunder and did not contain an
untrue statement of a material fact or omit to state a material fact required to
be stated therein or necessary to make the statements therein, in the light of
the circumstances under which they were made, not misleading; provided, however, that this
representation and warranty shall not apply to any statements or omissions made
in reliance upon and in conformity with information furnished in writing to the
Company by the Underwriter expressly for use therein; there are no contracts or
other documents required to be described in the Prospectus or to be filed as
exhibits to the Registration Statement which have not been described or filed as
required;
As used
in this subsection and elsewhere in this Agreement:
“Applicable
Time” means 7:00 p.m. (Eastern Time) on May 14, 2009.
“General
Disclosure Package” means (i) the Preliminary Prospectus, if any, used most
recently prior to the Time of Delivery, (ii) the Issuer-Represented Free Writing
Prospectuses, if any, identified in Schedule I hereto and
(iii) any other Free Writing Prospectus that the parties hereto shall hereafter
expressly agree in writing to treat as part of the General Disclosure
Package.
“Issuer-Represented
Free Writing Prospectus” means any “issuer free writing prospectus,” as defined
in Rule 433 of the 1933 Act Regulations (“Rule 433”), relating to the Shares
that (i) is required to be filed with the Commission by the Company or (ii) is
exempt from filing pursuant to Rule 433(d)(5)(i) because it contains a
description of the Shares or of the offering that does not reflect the final
terms, in each case in the form filed or required to be filed with the
Commission or, if not required to be filed, in the form retained in the
Company’s records pursuant to Rule 433(g).
Each
Issuer-Represented Free Writing Prospectus, when considered together with the
General Disclosure Package as of the Applicable Time, did not contain any untrue
statement of material fact or omit to state a material fact necessary to make
the statements therein, in light of the circumstances in which they were made,
not misleading and, did not, does not and will not include any information that
conflicted, conflicts or will conflict with the information contained in the
Registration Statement or the Prospectus, including any document incorporated by
reference therein and any preliminary or other prospectus deemed to be a part
thereof that, in each case, has not been superseded or modified.
(iii) The
Preliminary Prospectus, the Prospectus and each Issuer-Represented Free Writing
Prospectus when filed, if filed by electronic transmission, pursuant to XXXXX
(except as may be permitted by Regulation S-T under the Act), was identical to
the copy thereof delivered to the Underwriter for use in connection with the
offer and sale of the Shares; the Registration Statement conforms, and the
Prospectus and any further amendments or supplements to the Registration
Statement or the Prospectus will conform, in all material respects to the
requirements of the Act and the rules and regulations of the Commission
thereunder and do not and will not, as of the Effective Date, and as of the
applicable filing date as to the Prospectus and any amendment or supplement
thereto, contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements
therein in light of the circumstances in which they were made not misleading;
provided, however, that this
representation and warranty shall not apply to any statements or omissions made
in reliance upon and in conformity with information furnished in writing to the
Company by the Underwriter expressly for use therein;
(iv) The
documents which are incorporated or deemed to be incorporated by reference in
the Registration Statement or any Preliminary Prospectus or the Prospectus or
from which information is so incorporated by reference (the “Exchange Acts
Reports”), when they became effective or were filed with the Commission, as the
case may be (or, if an amendment with respect to any such documents was filed or
became effective, when such amendment was filed or became effective), complied
in all material respects to the requirements of the Securities Exchange Act of
1934, as amended (the “Exchange Act”), and the rules and regulations of the
Commission thereunder, and, when read together with the other information in the
Prospectus, at the time the Registration Statement became effective, at the
Applicable Time and at any Time of Delivery (as defined below) did not and will
not contain an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make to the statements
therein in light of the circumstances in which they were made not
misleading;
(v)
The financial statements, including the related
schedules and notes, filed with the Commission as a part of the Registration
Statement and included in the Preliminary Prospectus and the Prospectus (the
“Financial Statements”) present fairly the consolidated financial position of
the Company and its subsidiaries as of and at the dates indicated and the
results of their operations and cash flows for the periods specified; such
Financial Statements, unless otherwise noted therein have been prepared in
conformity with accounting principles generally accepted in the United States
(“GAAP”) applied on a consistent basis throughout the periods involved; no other
financial statements or supporting schedules are required to be included in the
Registration Statement, the Preliminary Prospectus and the Prospectus; the
income statement data, balance sheet data and earnings per share data for the
five fiscal years ended December 31, 2008 as set forth in the Prospectus under
the captions “Summary Consolidated Financial Data” fairly present the
information therein on a basis consistent with that of the audited financial
statements contained in the Registration Statement, the Preliminary Prospectus
and the Prospectus; the income statement data and earnings per share data for
the fiscal quarter ended March 31, 2009 and balance sheet data as of March 31,
2009 as set forth in the Prospectus under the caption “Summary Consolidated
Financial Data” fairly present the information therein on a basis consistent
with that of the unaudited financial statements contained in the Registration
Statement; to the extent applicable, all disclosures contained in the Prospectus
regarding “non-GAAP financial measures” as such term is defined by the rules and
regulations of the Commission comply with Regulation G of the Exchange Act, the
rules and regulations promulgated by the Commission thereunder and Item 10 of
Regulation S-K under the Act;
(vi) Xxxxx
Xxxxxxx LLP, the independent registered public accounting firm that certified
the financial statements of the Company and its subsidiaries, that are included
in or incorporated by reference into the Registration Statement and the
Prospectus is an independent registered public accounting firm as required by
the Act and the rules and regulations of the Commission thereunder, and such
accountants are not in violation of the auditor independence requirements of the
Xxxxxxxx-Xxxxx Act of 2002 (the “Xxxxxxxx-Xxxxx Act”) and the related rules and
regulations of the Commission;
(vii) The
statistical and market related data contained in the Prospectus and Registration
Statement are based on or derived from sources which the Company believes are
reliable and accurate;
(viii) This
Agreement has been duly authorized, executed and delivered by the Company and,
when duly executed by the Underwriter, will constitute the valid and binding
agreement of the Company enforceable against the Company in accordance with its
terms, except as enforcement thereof may be limited by bankruptcy, insolvency,
reorganization, moratorium or other similar laws relating to or affecting
creditors’ rights generally or by general equitable principles and except as any
indemnification or contribution provisions thereof may be limited under
applicable securities laws;
(ix)
Neither the Company nor any of its subsidiaries has
sustained, since the date of the latest audited financial statements included in
the Registration Statement and the Prospectus, any material loss or interference
with its business from fire, explosion, flood or other calamity, whether or not
covered by insurance, or from any labor dispute or court or governmental action,
order or decree, otherwise than as set forth or contemplated in the Prospectus;
and, since the respective dates as of which information is given in the
Registration Statement and the Prospectus, there has not been any material
change in the capital stock or long-term debt of the Company or any of its
subsidiaries or any material adverse change, or any development that may cause a
prospective material adverse change, in or affecting the general affairs,
management, earnings, business, properties, assets, current or future
consolidated financial position, business prospects, stockholders’ equity or
results of operations of the Company and its subsidiaries considered as one
enterprise, whether or not arising in the ordinary course of business and there
has been no effect with respect to the Company and its subsidiaries considered
as one enterprise, which would prevent, or be reasonably likely to prevent, the
Company from consummating the transaction contemplated by this Agreement (a
“Material Adverse Effect”), (B) there have been no transactions entered
into by the Company or any of its subsidiaries, other than those in the ordinary
course of business or as described in the Prospectus, which are material with
respect to the Company and its subsidiaries considered as one enterprise, and
(C) except for quarterly dividends on the Common Stock in amounts per share that
are consistent with past practice, there has been no dividend or distribution of
any kind declared, paid or made by the Company on any class of its capital
stock, otherwise than as set forth or contemplated in the Registration Statement
and the Prospectus;
(x) The
Company and its subsidiaries have good and marketable title in fee simple to all
real property and good and marketable title to all personal property owned by
them, in each case free and clear of all mortgages, pledges, security interests,
claims, restrictions, liens, encumbrances and defects except such as are
described in the Registration Statement and the Prospectus or such as do not
materially affect the value of such property and do not interfere with the use
made and proposed to be made of such property by the Company and its
subsidiaries; and any real property and buildings held under lease by the
Company and its subsidiaries are held by them under valid, subsisting and
enforceable leases with such exceptions as are not material and do not interfere
with the use made and proposed to be made of such property and buildings by the
Company and its subsidiaries, and neither the Company nor any Subsidiary has any
written, or to the Company’s knowledge, oral notice of any material claim of any
sort that has been asserted by anyone adverse to the rights of the Company or
any subsidiary under any of the leases or subleases mentioned above, or
affecting or questioning the rights of the Company or such Subsidiary to the
continued possession of the leased or subleased premises under any such lease or
sublease.
(xi) The
Company is a registered bank holding company under the Bank Holding Company Act
of 1956, as amended (“BHCA”) with respect to Bank of Smithtown (the “Bank”) and
has been duly incorporated and is validly existing as a corporation under the
laws of the jurisdiction of its incorporation, with the corporate power and
authority to own, lease and operate its properties and to conduct its business
as described in the Registration Statement and the Prospectus and to enter into
and perform its obligations under this Agreement; the Company is duly qualified
as a foreign corporation to transact business and is in good standing in each
other jurisdiction in which such qualification is required, whether by reason of
the ownership or leasing of property or the conduct of business, except where
the failure to so qualify or to be in good standing would not reasonably be
expected to result in a Material Adverse Effect;
(xii) Each
subsidiary of the Company has been duly incorporated and is validly existing as
a corporation, limited liability company, trust company, statutory business
trust or bank in good standing (where applicable) under the laws of the
jurisdiction of its incorporation and has the corporate power and authority to
own, lease and operate its properties and to conduct its business as described
in the Registration Statement and the Prospectus; each subsidiary of the Company
is duly qualified as a foreign corporation to transact business and is in good
standing in each other jurisdiction in which such qualification is required,
whether by reason of the ownership or leasing of property or the conduct of
business, except for such jurisdictions where the failure to so qualify, or be
in good standing, would not, individually or in the aggregate, reasonably be
expected to result in a Material Adverse Effect; all of the issued and
outstanding capital stock of each subsidiary has been duly authorized and
validly issued, is fully paid and nonassessable and is owned by the Company,
directly or through subsidiaries; the Company owns, directly or through
subsidiaries, the issued and outstanding capital stock of each subsidiary free
and clear of any security interest, mortgage, pledge, lien, encumbrance or
claim; the Company does not own or control, directly or indirectly, any
corporation, association or other entity other than the subsidiaries listed in
Exhibit 21 to the Company’s Annual Report on Form 10-K for the fiscal year ended
December 31, 2008; none of the outstanding shares of capital stock or other
equity interest of any subsidiary was issued in violation of the preemptive or
similar rights of any security holder or equity holder of such subsidiary; the
activities of the subsidiaries of the Bank are permitted to subsidiaries of a
New York chartered commercial bank and the deposit accounts of the Bank are
insured up to the applicable limits by the Federal Deposit Insurance Corporation
(the “FDIC”);
(xiii) The
Company has an authorized capitalization as set forth in the Prospectus under
the heading “Capitalization,” and all of the issued shares of capital stock of
the Company have been duly and validly authorized and issued, are fully paid and
non-assessable and have been issued in compliance with applicable federal and
state securities laws; none of the outstanding shares of Stock were issued in
violation of any preemptive rights, rights of first refusal or other similar
rights to subscribe for or purchase securities of the Company; the description
of the Company’s stock plans or arrangements and the awards granted thereunder,
set forth or incorporated by reference in the Prospectus, accurately and fairly
presents, in all material respects, the information required to be shown with
respect to such plans and arrangements;
(xiv) The
unissued Shares to be issued and sold by the Company to the Underwriter
hereunder have been duly and validly authorized and, when issued and delivered
against payment therefor as provided herein, will be duly and validly issued and
fully paid and non-assessable and will conform to the description of the Stock
contained in the Registration Statement and the Prospectus and the issuance of
the shares is not subject to the preemptive or other similar rights of any
security holder of the Company;
(xv) Except
as described in the Registration Statement and the Prospectus, (A) there are no
outstanding rights (contractual or otherwise), warrants or options to acquire,
or instruments convertible into or exchangeable for, or agreements or
understandings with respect to the sale or issuance of, any shares of capital
stock of or other equity interest in the Company; and (B) there are no
contracts, agreements or understandings between the Company and any person
granting such person the right to require the Company to file a Registration
Statement under the Act or otherwise register any securities of the Company
owned or to be owned by such person;
(xvi) The
issue and sale of the Shares by the Company and the compliance by the Company
with all of the provisions of this Agreement and the consummation of the
transactions herein contemplated have been duly authorized by all necessary
corporate action and do not and will not, whether with or without the giving of
notice or passage of time or both, conflict with or result in a breach or
violation of any of the terms or provisions of, or constitute a default or
result in a Repayment Event (as defined below) under, any indenture, mortgage,
deed of trust, loan agreement or other agreement or instrument to which the
Company or any of its subsidiaries is a party or by which the Company or any of
its subsidiaries is bound or to which any of the property or assets of the
Company or any of its subsidiaries is subject, nor will such action result in
any violation of the provisions of the certificate of incorporation or charter
(as applicable) or bylaws of the Company or any statute or any order, rule or
regulation of any federal, state, local or foreign court or governmental agency
(each a “Governmental Entity”) or body having jurisdiction over the Company or
any of its subsidiaries or any of their properties, except for these conflicts,
breaches, violations, defaults or Repayment Events that would not result in a
Material Adverse Effect; and no consent, approval, authorization, order,
registration or qualification of or with any such court or governmental agency
or body is required for the issue and sale of the Shares, the performance by the
Company of its obligations hereunder or the consummation by the Company of the
transactions contemplated by this Agreement, except the registration under the
Act of the Shares and except as may be required under the rules and regulations
of the Nasdaq Global Select Market or the Financial Industry Regulatory
Authority (“FINRA”) and such consents, approvals, authorizations, registrations
or qualifications as may be required under state securities or Blue Sky laws in
connection with the purchase and distribution of the Shares by the
Underwriter. As used herein, a “Repayment Event” means any event or
condition that gives the holder of any note, debenture or other evidence of
indebtedness (or any person acting on such holder’s behalf) the right to require
the repurchase, redemption or repayment of all or a portion of such indebtedness
by the Company or any subsidiary;
(xvii) Neither
the Company nor any of its subsidiaries is in violation of its certificate of
incorporation or charter (as applicable) or bylaws or in default in the
performance or observance of any obligation, agreement, covenant or condition
contained in any indenture, mortgage, deed of trust, loan or credit agreement,
note, lease or other agreement or instrument to which it is a party or by which
it or any of its properties may be bound or to which any of the property or
assets of the Company or any subsidiary is subject except for such defaults that
would not result in a Material Adverse Effect;
(xviii)
The statements set forth in the Prospectus under the caption “Description of our
Common Shares,” insofar as they purport to constitute a summary of the terms of
the capital stock of the Company, and under the caption “Underwriting,” insofar
as they purport to describe the provisions of the laws and documents referred to
therein, are accurate and complete;
(xix)
Except as disclosed in the Registration Statement and the Prospectus, the
Company and its subsidiaries are conducting their respective businesses in
compliance in all material respects with all federal, state, local and foreign
statutes, laws, rules, regulations, decisions, directives and orders applicable
to them (including, without limitation, all regulations and orders of, or
agreements with, the New York State Banking Department, the Federal Reserve
Board (the “FRB”) and the FDIC, the Equal Credit Opportunity Act, the Fair
Housing Act, the Community Reinvestment Act, the Home Mortgage Disclosure Act,
all other applicable fair lending laws or other laws relating to discrimination
and the Bank Secrecy Act and Title III of the USA Patriot Act), and neither the
Company nor any of its subsidiaries has received any written, or to the
Company’s knowledge, oral communication from any Governmental Entity asserting
that the Company or any of its subsidiaries is not in material compliance with
any statute, law, rule, regulation, decision, directive or order;
(xx) Except
as disclosed in the Registration Statement and the Prospectus, there are no
legal or governmental actions or suits, investigations, inquiries or proceedings
before or by any court or Government Entity, now pending or, to the knowledge of
the Company, threatened or contemplated, to which the Company or any of its
subsidiaries is a party or of which any property of the Company or any of its
subsidiaries is the subject (A) that is required to be disclosed in the
Registration Statement by the Act or by the rules and regulations of the
Commission thereunder and not disclosed therein or (B) which, if determined
adversely to the Company or any of its subsidiaries, would, individually or in
the aggregate, have a Material Adverse Effect; all pending legal or governmental
proceedings to which the Company or any of its subsidiaries is a party or of
which any of their property is the subject, either individually or in the
aggregate, which are not described in the Registration Statement, including
ordinary routine litigation incidental to their respective businesses, would not
have a Material Adverse Effect; and there are no contracts or documents of the
Company or any of its subsidiaries which would be required to be described in
the Registration Statement or to be filed as exhibits thereto by the Act or by
the rules and regulations of the Commission thereunder which have not been so
described and filed;
(xxi) Each
of the Company and its subsidiaries possess all permits, licenses, approvals,
consents and other authorizations of (collectively, “Governmental Licenses”),
and has made all filings, applications and registrations with, all Governmental
Entities to permit the Company or such subsidiary to conduct the business now
operated by the Company or its subsidiaries; the Company and its subsidiaries
are in compliance with the terms and conditions of all such Governmental
Licenses, except where the failure to so comply would not, individually or in
the aggregate, have a Material Adverse Effect; all of the Governmental Licenses
are valid and in full force and effect, except where the invalidity of such
Governmental Licenses or the failure of such Governmental Licenses to be in full
force and effect would not, individually or in the aggregate, have a Material
Adverse Effect; and neither the Company nor any of its subsidiaries has received
any notice of proceedings relating to the revocation or modification of any such
Governmental Licenses which, singly or in the aggregate, if the subject of an
unfavorable decision, ruling or finding, would result in a Material Adverse
Effect;
(xxii) Except
as described in the Prospectus and except as would not, singly or in the
aggregate, result in a Material Adverse Effect, (A) neither the Company nor any
of its subsidiaries is in violation in any material respect of any federal,
state or local statute, law, rule, regulation, ordinance, code, policy or rule
of common law or any judicial or administrative interpretation thereof,
including any judicial or administrative order, consent, decree or judgment,
relating to pollution or protection of human health, the environment (including,
without limitation, ambient air, surface water, groundwater, land surface or
subsurface strata) or wildlife, including, without limitation, laws and
regulations relating to the release or threatened release of chemicals,
pollutants, contaminants, wastes, toxic substances, hazardous substances,
petroleum or petroleum products, asbestos-containing materials or mold
(collectively, “Hazardous Materials”) or to the manufacture, processing,
distribution, use, treatment, storage, disposal, transport or handling of
Hazardous Materials (collectively, “Environmental Laws”), (B) the Company and
its subsidiaries have all material permits, authorizations and approvals
required under any applicable Environmental Laws and are each in material
compliance with their requirements, and (C) there are no material pending, or to
the Company’s knowledge, threatened administrative, regulatory or judicial
actions, suits, demands, demand letters, claims, liens, notices of noncompliance
or violation, investigation or proceedings relating to any Environmental Law
against the Company or any of its subsidiaries.
(xxiii) The
Company and each of its subsidiaries own or possess adequate rights to use or
can acquire on reasonable terms ownership or rights to use all material patents,
patent applications, patent rights, licenses, trademarks, service marks, trade
names, trademark registrations, service xxxx registrations, copyrights, know-how
(including trade secrets and other unpatented and/or unpatenable property or
confidential information, systems or procedures and excluding generally
commercially available “off the shelf” software programs licensed pursuant to
shrink wrap or “click and accept” licenses) and licenses (collectively,
“Intellectual Property”) necessary for the conduct of their respective
businesses and have no reason to believe that the conduct of their respective
businesses will conflict with, and have not received any notice of any claim of
infringement or conflict with, any such rights of others or any facts or
circumstances that would render any Intellectual Property invalid or inadequate
to protect the interest of the Company or any of its subsidiaries therein, and
which infringement or conflict (if the subject of any unfavorable decision,
ruling or finding) or invalidity or inadequacy, singly or in the aggregate,
would result in a Material Adverse Effect;
(xxiv) No
relationship, direct or indirect, exists between or among the Company or any of
its subsidiaries on the one hand, and the directors, officers, shareholders,
customers or suppliers of the Company or any of its subsidiaries on the other
hand, which is required to be described in the Registration Statement and the
Prospectus by the Act or by the rules and regulations of the Commission
thereunder which has not been so described;
(xxv) The
Company is not and, after giving effect to the offering and sale of the Shares
and after receipt of payment for the Shares and the application of such proceeds
as described in the Prospectus, will not be an “investment company” or an entity
“controlled” by an “investment company”, as such terms are defined in the
Investment Company Act of 1940, as amended (the “Investment Company
Act”);
(xxvi)
There is and has been no failure on the part of the Company or any of the
Company’s directors or officers, in their capacities as such, to comply in all
material respects with any provision of the Xxxxxxxx-Xxxxx Act of 2002 and the
rules and regulations promulgated in connection therewith (the “Xxxxxxxx-Xxxxx
Act”), including Section 402 related to loans and Sections 302 and 906 related
to certifications;
(xxvii) Neither
the Company nor any of its subsidiaries, nor any affiliates of the Company or
its subsidiaries has taken and will not take, directly or indirectly, any action
designed to or that might be reasonably expected to cause or result in
stabilization or manipulation of the price of the Stock to facilitate the sale
or resale of the Shares;
(xxiii) Neither
the Company nor any of its subsidiaries nor, to the Company’s knowledge, any
director, officer, employee or agent or other person associated with or acting
on behalf of the Company or any of its subsidiaries has (A) used any corporate
funds for any unlawful contribution, gift, entertainment or other unlawful
expense relating to political activity; (B) made any direct or indirect unlawful
payment to any foreign or domestic government official or employee from
corporate funds; (C) violated or is in violation of any provision of the Foreign
Corrupt Practices Act of 1977; or (D) made any bribe, rebate, payoff, influence
payment, kickback or other unlawful payment;
(xxix)
The Company and each of its subsidiaries maintains a system of internal
accounting controls sufficient to provide reasonable assurances that (A)
transactions are executed in accordance with management’s general or specific
authorization; (B) transactions are recorded as necessary to permit preparation
of financial statements in conformity with GAAP and to maintain accountability
for assets; (C) access to assets is permitted only in accordance with
management’s general or specific authorization; and (D) the recorded
accountability for assets is compared with existing assets at reasonable
intervals and appropriate action is taken with respect to any
differences. Since the end of the Company’s most recent audited
fiscal year, there has been (x) no material weakness in the Company’s internal
control over financial reporting (whether or not remediated) and (y) no change
in the Company’s internal control over financial reporting that has materially
affected, or is reasonably likely to materially affect, the Company’s internal
control over financial reporting;
(xxx)
The Company has established and maintained disclosure controls and procedures
(as such term is defined in Rule 13a-15(e) and 15d-15(e) under the Exchange
Act), which (A) are designed to ensure that information required to be disclosed
by the Company in the reports that it files or submits under the 1934 Act is
recorded, processed, summarized and reported within the time periods specified
in the Commission’s rules and forms and that material information relating to
the Company and its subsidiaries is made known to the Company’s principal
executive officer and principal financial officer by others within the Company
and its subsidiaries to allow timely decisions regarding disclosure, and (B) are
effective in all material respects to perform the functions for which they were
established. Based on the evaluation of the Company’s disclosure
controls and procedures, taken as a whole, described above, the Company is not
aware of (x) any significant deficiency in the design or operation of internal
controls which could adversely affect the Company’s ability to record, process,
summarize and report financial data or any material weaknesses in internal
controls or (y) any fraud, whether or not material, that involves management or
other employees who have a significant role in the Company’s internal
controls. Since the most recent evaluation of the Company’s
disclosure controls and procedures described above, there have been no
significant changes in internal controls or in other factors that could
significantly affect internal controls.
(xxxi) Neither
the Company nor any of its subsidiaries is subject or is party to, or has
received any notice or advice that any of them may become subject or party to
any investigation with respect to, any corrective, suspension or
cease-and-desist order, agreement, memorandum of understanding, consent
agreement or other regulatory enforcement action, proceeding or order with or
by, or is a party to any commitment letter or similar undertaking to, or is
subject to any directive by, or has been a recipient of any supervisory letter
from, or has adopted any board resolutions at the request of, any Governmental
Entity charged with the supervision or regulation of depository institutions or
engaged in the insurance of deposits (including the FDIC) or the supervision or
regulation of the Company or any of its subsidiaries that currently relates to
or restricts in any material respect their business or their management (each, a
“Regulatory Agreement”), nor has the Company or any of its subsidiaries been
advised by any such Governmental Entity that it is considering issuing or
requesting any such Regulatory Agreement; there is no unresolved violation,
criticism or exception by any such Governmental Entity with respect to any
report or statement relating to any examinations of the Company or any of its
subsidiaries which, in the reasonable judgment of the Company, currently results
in or is expected to result in a Material Adverse Effect;
(xxxii) Except
as separately disclosed in writing to the Underwriter, any “employee benefit
plan” (as defined under the Employee Retirement Income Security Act of 1974, as
amended, and the regulations and published interpretations thereunder
(collectively, “ERISA”)) established or maintained by the Company, its
subsidiaries or their “ERISA Affiliates” (as defined below) are in compliance in
all material respects with ERISA; “ERISA Affiliate” means, with respect to the
Company or a subsidiary, any member of any group of organizations described in
Section 414(b), (c), (m) or (o) of the Internal Revenue Code of 1986, as
amended, and the regulations and published interpretations thereunder (the
“Code”) of which the Company or such subsidiary is a member; no “reportable
event” (as defined under ERISA) has occurred or is reasonably expected to occur
with respect to any “employee benefit plan” established or maintained by the
Company, its subsidiaries or any of their ERISA Affiliates; no “employee benefit
plan” established or maintained by the Company, its subsidiaries or any of their
ERISA Affiliates, if such “employee benefit plan” were terminated, would have
any “amount of unfunded benefit liabilities” (as defined under ERISA); none of
the Company, its subsidiaries nor any of their ERISA Affiliates has incurred or
reasonably expects to incur any liability under (A) Title IV of ERISA with
respect to termination of, or withdrawal from, any “employee benefit plan” or
(B) Sections 412, 4971, 4975 or 4980B of the Code; each “employee benefit plan”
established or maintained by the Company, its subsidiaries or any of their ERISA
Affiliates that is intended to be qualified under Section 401(a) of the Code has
received a favorable determination or approval letter from the Internal Revenue
Service regarding its qualification under such section and nothing has occurred
whether by action or failure to act, which would cause the loss of such
qualification;
(xxxiii) The
Company and its subsidiaries, taken as a whole, are insured against such losses
and risks and in such amounts as are prudent and customary in the business in
which they are engaged; and neither the Company nor any of its subsidiaries has
any reason to believe that it will not be able to renew its existing insurance
coverage from similar insurers as may be necessary to continue its business at a
cost that would not have a Material Adverse Effect; neither the Company nor any
subsidiary has been denied any insurance coverage which it has sought or for
which it has applied;
(xxxiv) Except as
disclosed in the Registration Statement and the Prospectus, there are no
contracts, agreements or understandings between the Company and any person that
would give rise to a valid claim against the Company, or the Underwriter, for a
brokerage commission, finder’s fee or other like payment as a result of the
transactions contemplated by this Agreement;
(xxxv) The
Company and its consolidated subsidiaries and its other subsidiaries have filed
all necessary federal, state and foreign income and franchise tax returns or
have properly requested extensions thereof, all such tax returns are true,
complete and correct and have paid all taxes required to be paid by any of them;
the Company has made adequate charges, accruals and reserves in the applicable
financial statements referred to in Section 1(a)(v) above in respect of all
federal, state and foreign income and franchise taxes for all periods as to
which the tax liability of the Company or any of its consolidated subsidiaries
or any of its other subsidiaries has not been finally determined;
(xxxvi) No
labor dispute with the employees of the Company or any subsidiary exists or, to
the knowledge of the Company, is imminent, which, in any case, may reasonably be
expected to result in a Material Adverse Effect;
(xxxvii) Except as
disclosed in the Registration Statement and the Prospectus, the operations of
the Company and its subsidiaries are and have been conducted at all times in
compliance in all material respects with applicable financial recordkeeping and
reporting requirements of the Currency and Foreign Transactions Reporting Act of
1970, as amended, money laundering statutes applicable to the Company and its
subsidiaries, the rules and regulations thereunder and any related or similar
rules, regulations or guidelines, issued, administered or enforced by any
governmental agency (collectively, the “Money Laundering Laws”);
(xxxviii) The
Registration Statement is not the subject of a pending proceeding or examination
under Section 8(d) or 8(e) of the Act, and the Company is not the subject of a
pending proceeding under Section 8A of the Act in connection with the offering
of the Shares;
(xxxix) The
Company has not distributed and, prior to the later to occur of (i) the Closing
Time and (ii) completion of the distribution of the Shares, will not distribute
any prospectus (as such term is defined in the Act and the rules and regulations
promulgated by the Commission thereunder) in connection with the offering and
sale of the Shares other than the Registration Statement, any Preliminary
Prospectus, the Prospectus or other materials, if any, permitted by the Act or
by the rules and regulations promulgated by the Commission thereunder
and approved by the Underwriter;
(xl) No
forward-looking statement (within the meaning of Section 27A of the Act and
Section 21E of the Exchange Act) contained in the Registration Statement, the
Prospectus and any Issuer-Represented Free Writing Prospectus has been made or
reaffirmed without a reasonable basis or has been disclosed other than in good
faith;
(xli) Each
of the Company’s executive officers and directors and certain stockholders, in
each case as listed on Schedule II hereto,
will, prior to closing, execute and deliver a lock-up agreement substantially in
the form of Exhibit
A;
(xlii) Neither
the Company nor any of its subsidiaries has participated in any reportable
transaction, as defined in Treasury Regulation Section
1.6011-(4)(b)(1);
(xliii) Each
of the Company and its subsidiaries has good and marketable title to all
securities held by it (except securities sold under repurchase agreements or
held in any fiduciary or agency capacity) free and clear of any lien, claim,
charge, option, encumbrance, mortgage, pledge or security interest or other
restriction of any kind, except to the extent such securities are pledged in the
ordinary course of business consistent with prudent business practices to secure
obligations of the Company or any of its subsidiaries and except for such
defects in title or liens, claims, charges, options, encumbrances, mortgages,
pledges or security interests or other restrictions of any kind that would not
be material to the Company and its subsidiaries. Such securities are valued on
the books of the Company and its subsidiaries in accordance with GAAP;
and
(xliv) Any
and all material swaps, caps, floors, futures, forward contracts, option
agreements (other than employee stock options) and other derivative financial
instruments, contracts or arrangements, whether entered into for the account of
the Company or one of its subsidiaries or for the account of a customer of the
Company or one of its subsidiaries, were entered into in the ordinary course of
business and in accordance with prudent business practice and applicable laws,
rules, regulations and policies of all applicable regulatory agencies and with
counterparties believed to be financially responsible at the time. The Company
and each of its subsidiaries have duly performed in all material respects all of
their obligations thereunder to the extent that such obligations to perform have
accrued, and there are no breaches, violations or defaults or allegations or
assertions of such by any party thereunder.
(b) Any
certificate signed by an officer of the Company or the Bank and delivered to you
or to counsel for the Underwriter shall be deemed to be a representation and
warranty by the Company or the Bank, as the case may be, to the Underwriter as
to the matters set forth therein.
2. Subject
to the terms and conditions herein set forth, (a) the Company agrees to issue
and sell to the Underwriter, and the Underwriter agrees, to purchase from the
Company, at a purchase price per share of $9.55, the Firm Shares and (b) in the
event and to the extent that the Underwriter shall exercise its election to
purchase Optional Shares as provided below, the Company agrees to issue and sell
to the Underwriter, and the Underwriter agrees to purchase from the Company, at
the purchase price per share set forth in clause (a) of this Section 2, the
Optional Shares.
Subject to the terms and conditions
herein set forth, the Company hereby grants to the Underwriter the right to
purchase at its election up to 200,000 Optional Shares, at the purchase price
per share set forth in clause (a) of the paragraph above, for the sole purpose
of covering sales of shares in excess of the number of Firm
Shares. Any such election to purchase Optional Shares may be
exercised only by written notice from you to the Company, given within a period
of 30 calendar days after the date of this Agreement, setting forth the
aggregate number of Optional Shares to be purchased and the date on which such
Optional Shares are to be delivered, as determined by you but in no event
earlier than the First Time of Delivery (as defined in Section 4 hereof) or,
unless you and the Company otherwise agree in writing, no earlier than two or
later than ten business days after the date of such notice.
3. Upon
the authorization by the Company of the release of the Firm Shares, the
Underwriter proposes to offer the Firm Shares for sale upon the terms and
conditions set forth in the Prospectus.
4. (a)
The Shares to be purchased by the Underwriter hereunder,
in definitive form, and in such authorized denominations and registered in such
names as the Underwriter may request upon at least 48 hours’ prior notice to the
Company, shall be delivered by or on behalf of the Company to the Underwriter
through the facilities of the Depository Trust Company (“DTC”), for the account
of the Underwriter, against payment by or on behalf of the Underwriter of the
purchase price therefor by wire transfer of Federal (same day) funds to the
account specified by the Company to the Underwriter at least 48 hours in
advance. The Company will cause the certificates representing the
Shares to be made available for checking and packaging at least 24 hours prior
to the Time of Delivery (as defined below) with respect thereto at the office of
DTC or its designated custodian (the “Designated Office”). The time
and date of such delivery and payment shall be, with respect to the Firm Shares,
10:00 a.m., Eastern time, on May 20, 2009 or such other time and date as the
Underwriter and the Company may agree upon in writing, and, with respect to the
Optional Shares, 10:00 a.m., New York time, on the date specified by the
Underwriter in the written notice given by the Underwriter of its election to
purchase such Optional Shares, or such other time and date as the Underwriter
and the Company may agree upon in writing. Such time and date for
delivery of the Firm Shares is herein called the “First Time of Delivery,” such
time and date for delivery of the Optional Shares, if not the First Time of
Delivery, is herein called the “Second Time of Delivery,” and each such time and
date for delivery is herein called a “Time of Delivery.”
(b) The
documents to be delivered at each Time of Delivery by or on behalf of the
parties hereto pursuant to Section 7 hereof, including the cross receipt for the
Shares and any additional documents requested by the Underwriter pursuant to
Section 7(k) hereof, will be delivered at the offices of Xxxxxxxxxx Xxxxxxxx
LLP, 000 00xx Xxxxxx,
X.X., Xxxxx 000, Xxxxxxxxxx, X.X. 00000 (the “Closing Location”), and
the Shares will be delivered at the Designated Office, all at such Time of
Delivery. A meeting will be held at the Closing Location at 10:00
a.m., Eastern Time, on the New York Business Day next preceding such Time of
Delivery, at which meeting the final drafts of the documents to be delivered
pursuant to the preceding sentence will be available for review by the parties
hereto. For the purposes of this Section 4, “New York Business Day”
shall mean each Monday, Tuesday, Wednesday, Thursday and Friday, which is not a
day on which banking institutions in New York are generally authorized or
obligated by law or executive order to close.
5. The
Company agrees with the Underwriter:
(a) To
prepare the Prospectus in a form approved by you and to file such Prospectus
pursuant to Rule 424(b) under the Act not later than the Commission’s close of
business on the second business day following the execution and delivery of this
Agreement, or, if applicable, such earlier time as may be required by Rule
430A(a)(3) under the Act; to make no further amendment or any supplement to the
Registration Statement or the Prospectus which shall be disapproved by you
promptly after reasonable notice thereof; to advise you, promptly after it
receives notice thereof, of the time when any amendment to the Registration
Statement has been filed or becomes effective or any supplement to the
Prospectus or any amended Prospectus has been filed and to furnish you with
copies thereof; to advise you, promptly after it receives notice thereof, of the
issuance by the Commission of any stop order or of any order preventing or
suspending the use of any Preliminary Prospectus or Prospectus, of the
suspension of the qualification of the Shares for offering or sale in any
jurisdiction, of the initiation or threatening of any proceeding for any such
purpose, or of any request by the Commission for the amending or supplementing
of the Registration Statement or the Prospectus or for additional information;
and, in the event of the issuance of any stop order or of any order preventing
or suspending the use of any Preliminary Prospectus or prospectus or suspending
any such qualification, promptly to use its best efforts to obtain the
withdrawal of such order;
(b) Promptly
from time to time to take such action as you may reasonably request to qualify
the Shares for offering and sale under the securities laws of such jurisdictions
as you may request and to comply with such laws so as to permit the continuance
of sales and dealings therein in such jurisdictions for as long as may be
necessary to complete the distribution of the Shares, provided that in
connection therewith the Company shall not be required to qualify as a foreign
corporation or to file a general consent to service of process in any
jurisdiction;
(c) Prior
to 10:00 a.m., Eastern Time, on the New York Business Day next succeeding the
date of this Agreement and from time to time, to furnish the Underwriter with
copies of the Prospectus in New York City in such quantities as you may from
time to time reasonably request, and, if the delivery of a prospectus is
required at any time prior to the expiration of nine months after the time of
issue of the Prospectus in connection with the offering or sale of the Shares
and if at such time any event shall have occurred as a result of which the
Prospectus as then amended or supplemented would include an untrue statement of
a material fact or omit to state any material fact necessary in order to make
the statements therein, in the light of the circumstances under which they were
made when such Prospectus is delivered, not misleading, or, if for any other
reason it shall be necessary during such period to amend or supplement the
Prospectus in order to comply with the Act, to notify you and upon your request
to prepare and furnish without charge to each Underwriter and to any dealer in
securities as many copies as you may from time to time reasonably request of an
amended Prospectus or a supplement to the Prospectus which will correct such
statement or omission or effect such compliance, and in case the Underwriter is
required to deliver a prospectus in connection with sales of any of the Shares
at any time nine months or more after the time of issue of the Prospectus, upon
your request but at the expense of the Underwriter, to prepare and deliver to
the Underwriter as many copies as you may request of an amended or supplemented
Prospectus complying with Section 10(a)(3) of the Act;
(d) To
make generally available to its securityholders as soon as practicable, an
earnings statement of the Company and its subsidiaries (which need not be
audited) complying with Section 11(a) of the Act and the rules and regulations
thereunder (including, at the option of the Company, Rule 158);
(e) During
the period beginning from the date hereof and continuing to and including the
date 90 days after the date of the Prospectus, not to directly or indirectly,
offer, sell, contract or grant any option to sell, pledge, transfer or establish
an open “put equivalent position” within the meaning of Rule 16a-l(h) under the
Exchange Act, or otherwise dispose of or transfer, or announce the offering of,
or file a registration statement under the Act in respect of, except as provided
hereunder, any securities of the Company that are substantially similar to the
Shares, including but not limited to any securities that are convertible into or
exchangeable for, or that represent the right to receive, Stock or any such
substantially similar securities, without your prior written consent with the
exception of the warrants separately disclosed in writing to the Underwriter;
provided, however, that if: (1) during the last 17 days of such 90-day period
the Company issues an earnings release or material news or a material event
relating to the Company occurs; or (2) prior to the expiration of such 180-day
period, the Company announces that it will release earnings results during the
16-day-period beginning on the last day of such 90-day period, the restrictions
imposed by this Section 5(e) shall continue to apply until the expiration of the
18-day period beginning on the issuance of the earnings release or the
occurrence of the material news or material event. The foregoing
sentence shall not apply to (A) the Shares to be sold hereunder, (B) any shares
of Stock issued by the Company upon the exercise of an option or warrant or the
conversion of a security outstanding on the date hereof and referred to in the
Prospectus, (C) any shares of Stock issued or options to purchase Stock granted
pursuant to existing employee benefit plans of the Company or (D) any shares of
Stock issued by the Company in connection with an acquisition by or merger of
the Company;
(f) To
use the net proceeds received by it from the sale of the Shares pursuant to this
Agreement in the manner specified in the Prospectus under the caption “Use of
Proceeds”;
(g) If
the Company elects to rely on Rule 462(b), the Company shall file a Rule 462(b)
Registration Statement with the Commission in compliance with Rule 462(b) by
10:00 p.m., Eastern time on the date of this Agreement, and the Company shall at
the time of filing either pay to the Commission the filing fee for the Rule
462(b) Registration Statement or give irrevocable instructions for the payment
of such fee pursuant to Rule 111(b) under the Act;
(h) To
use its best efforts to list for quotation the Shares on the Nasdaq Global
Select Market;
(i)
Until completion of the distribution of the Shares, the Company will
file all documents required to be filed with the Commission pursuant to the
Exchange Act within the time periods required by the Exchange Act and the rules
and regulations of the Commission thereunder; and
(j)
That unless it obtains the prior consent of the
Underwriter, and the Underwriter represents and agrees that, unless it obtains
the prior consent of the Company, they have not made and will not make any offer
relating to the Shares that would constitute an Issuer-Represented Free Writing
Prospectus complied and will comply with the requirements of Rule 433 applicable
to any Issuer-Represented Free Writing Prospectus, including where and when
required timely filing with the Commission, legending and record
keeping. The Company represents that it has satisfied and agrees that
it will satisfy the conditions in Rule 433 to avoid a requirement to file with
the Commission any electronic road show.
6. The
Company covenants and agrees with the Underwriter that the Company will pay or
cause to be paid the following, whether or not the transactions contemplated
herein are completed: (i) the reasonable out-of-pocket expenses incurred by the
Underwriter in connection with the transactions contemplated hereby, including,
without limitation, disbursements, fees and expenses of Underwriter’s counsel
(which fees and expenses will not exceed $150,000) and marketing, syndication
and travel expenses; (ii) the fees, disbursements and expenses of the Company’s
counsel and accountants in connection with the registration of the Shares under
the Act and all other expenses in connection with the preparation, printing and
filing of amendments and supplements thereto and the mailing and delivering of
copies thereof to the Underwriter and dealers; (iii) the cost of printing or
producing any agreement among Underwriter’s this Agreement, the Blue Sky survey,
closing documents (including any compilations thereof) and any other documents
in connection with the offering, purchase, sale and delivery of the Shares; (iv)
all expenses in connection with the qualification of the Shares for offering and
sale under state securities laws as provided in Section 5(b) hereof, including
the fees and disbursements of counsel for the Underwriter in connection with
such qualification and in connection with the Blue Sky survey; (v) all fees and
expenses in connection with listing the Shares on the Nasdaq Global Select
Market; (vi) the filing fees incident to any required review by the FINRA of the
terms of the sale of the Shares; (vii) the cost of preparing stock certificates;
(viii) the cost and charges of any transfer agent or registrar; (ix) the costs
and expenses of the Company relating to investor presentations on any “road
show” undertaken in connection with the marketing of the Shares, including
without limitation, expenses associated with the production of road show slides
and graphics, fees and expenses of any consultants engaged in connection with
the road show presentations, travel and lodging expenses of the representatives
and officers of the Company and any such consultants, and the cost of aircraft
and other transportation chartered in connection with the road show with the
consent of the Company; and (x) all other costs and expenses incident to the
performance of its obligations hereunder which are not otherwise specifically
provided for in this Section.
7. The
obligations of the Underwriter hereunder, as to the Shares to be delivered at
each Time of Delivery, shall be subject, in their discretion, to the condition
that all representations and warranties and other statements of the Company
herein are, at and as of such Time of Delivery, true and correct, the condition
that the Company shall have performed all of its obligations hereunder
theretofore to be performed, and the following additional
conditions:
(a) The
Prospectus shall have been filed with the Commission pursuant to Rule 424(b)
within the applicable time period prescribed for such filing by the rules and
regulations under the Act and in accordance with Section 5(a) hereof (or a
post-effective amendment shall have been filed and declared effective in
accordance with the requirements of Rule 430A); if the Company has elected to
rely upon Rule 462(b), the Rule 462(b) Registration Statement shall have become
effective by 10:00 p.m., Eastern Time, on the date of this Agreement; no stop
order suspending the effectiveness of the Registration Statement or any part
thereof shall have been issued and no proceeding for that purpose shall have
been initiated or to the Company’s knowledge threatened by the Commission; and
all requests for additional information on the part of the Commission shall have
been complied with to your reasonable satisfaction; and the FINRA shall have
raised no objection to the fairness and reasonableness of the underwriting terms
and arrangements;
(b) Xxxxxxxxxx
Xxxxxxxx LLP, counsel for the Underwriter, shall have furnished to you such
written opinion or opinions, dated such Time of Delivery, with respect to such
matters as you may reasonably request, and such counsel shall have received such
papers and information as they may reasonably request to enable them to pass
upon such matters;
(c) Xxxx
Xxxxxx Xxxxxxxx & Xxxxxx, P.C., counsel for the Company, shall have
furnished to you their written opinion (and with your consent may rely on the
written opinion of local counsel for portions of the opinion below), dated such
Time of Delivery, in form and substance satisfactory to you, to the effect
that:
(i)
The Company is duly registered as a bank
holding company under the BHCA; the Company is validly existing as a corporation
under the laws of the State of New York, with corporate power and authority to
own, lease and operate its properties and conduct its business as described in
the Prospectus and to enter into and perform its
obligations under this Agreement;
(ii) The
authorized, issued and outstanding capital stock of the Company is as set forth
in the Prospectus in the column entitled “Actual” under the caption
“Capitalization” (except for subsequent issuances, if any, pursuant to this
Agreement, pursuant to reservations, agreements or employee benefit plans
referred to in the Prospectus or pursuant to the exercise of convertible
securities or options referred to in the Prospectus); all of the shares of the
Company’s issued and outstanding capital stock have been duly authorized and
validly issued and are fully paid and non-assessable, and none of the
outstanding shares of capital stock were issued in violation of the preemptive
or other similar rights of any securityholder of the Company; and the Shares
conform to the description of the Stock contained in the
Prospectus;
(iii) Except
as described in the Prospectus, (A) there are no outstanding rights (contractual
or otherwise), warrants or options to acquire, or instruments convertible into
or exchangeable for, or agreements or understandings with respect to the sale or
issuance of, any shares of capital stock of or other equity interest in the
Company, except pursuant to the Company’s stock plans and awards currently in
effect on the date hereof; and (B) there are no contracts, agreements or
understandings between the Company and any person granting such person the right
to require the Company to file a registration statement under the Act or
otherwise register any securities of the Company owned or to be owned by such
person;
(iv) The
Company is duly qualified as a foreign corporation to transact business and is
in good standing under the laws of each other jurisdiction in which such
qualification is required, whether by reason of the ownership or leasing of
property or the conduct of business, except where such failure to so qualify, or
be in good standing, would not have a Material Adverse Effect;
(v) Each
of the Company’s subsidiaries either is
validly existing as a corporation or a New York chartered commercial bank, and
in the case of the Company’s Maryland subsidiary, in good standing under the
laws of the jurisdiction of its incorporation, and each Company subsidiary has
the corporate power and authority to own, lease and operate its properties and
to conduct its business as described in the Prospectus; each of the Company’s subsidiaries is duly qualified as a foreign
corporation to transact business and is in good standing in each other
jurisdiction in which such qualification is required, whether by reason of the
ownership or leasing of property or the conduct of business, except where the
failure to so qualify, or be in good standing would not, individually or in the
aggregate, have a Material Adverse Effect; the activities of the subsidiaries of
the Bank as described in the Prospectus are activities permitted to subsidiaries
of a New York chartered commercial bank under applicable law and the rules and
regulations of the New York State Banking Department; the deposit accounts of
the Bank are insured up to the applicable limits by the FDIC; all of the issued
and outstanding capital stock of each subsidiary has been duly authorized and
validly issued, is fully paid and nonassessable and is owned by the Company,
directly or through subsidiaries free and clear of any security interest,
mortgage, pledge, lien, encumbrance or claim; none of the outstanding shares of
capital stock were issued in violation of the preemptive or other similar rights
of any security holder of such security; and the Company and Bank have all
necessary consents and approvals under applicable federal and state laws and
regulations relating to banks and bank holding companies to own their respective
assets and carry on their respective businesses as described in the Prospectus,
except for those consents and approvals that would not have a Material Adverse
Effect;
(vi) This
Agreement has been duly authorized, executed and delivered by the
Company;
(vii) The
issue and sale of the Shares being delivered at such Time of Delivery by the
Company and the compliance by the Company with all of the provisions of this
Agreement and the consummation of the transactions herein contemplated will not
(a) require any consent, approval, license or exemption by, order or
authorization of, or filing, recording or registration by the Company with any
state or federal governmental authority, except such as have been made or
obtained under the Act and as may be required under the rules and regulations of
the Nasdaq Global Select Market or the FINRA and such consents, approvals,
authorizations, registrations or qualifications as may be required under state
securities or Blue Sky laws in connection with the purchase and distribution of
the Shares by the Underwriter, (b) conflict with or result in a breach or
violation of any of the terms or provisions of, or constitute a default under,
any indenture, mortgage, deed of trust, loan agreement or other agreement or
instrument known to such counsel to which the Company or any of its subsidiaries
is a party or by which the Company or any of its subsidiaries is bound or to
which any of the property or assets of the Company or any of its subsidiaries is
subject or (c) result in any violation of the provisions of the certificate of
incorporation or charter (as applicable) or bylaws of the Company or any statute
or any order, rule or regulation of any court or Governmental Entity (except
that no opinion with respect to the securities and blue sky laws of various
jurisdictions or the rules or regulations of FINRA and the Nasdaq Global Select
Market need be rendered);
(viii)
Neither the Company nor any of its subsidiaries is in violation of its
certificate of incorporation or charter (as applicable) or bylaws and no default
by the Company or any subsidiary exists in the due performance or observance of
any obligation, agreement, covenant or condition contained in any contract,
indenture, mortgage, deed of trust, loan agreement, note lease or other
agreement or instrument to which it is a party or by which it or any of its
properties may be bound that is described or referred to in the Prospectus,
except for such defaults, that, singly or in the aggregate, would not have a
Material Adverse Effect;
(ix) The
statements set forth in the Prospectus under the caption “Description of Our
Common Shares,” as such statements contain descriptions of laws, rules or
regulations, and insofar as they describe the terms of agreements or the
Company’s certificate of incorporation or bylaws, are correct in all material
respects.
(x) The
Company has all necessary approvals of the Board of Governors of the Federal
Reserve System (the “FRB”) to own the stock of its subsidiaries.
(xi) The
Company is not, and after giving effect to the offering and sale of the Shares
and after receipt of payment for the Shares and the application of such proceeds
as described in the Prospectus, will not be, an “investment company” or an
entity “controlled” by an “investment company,” as such terms are defined in the
Investment Company Act;
(xii) The
documents incorporated by reference in the Prospectus (other than the financial
statements, pro forma and related schedules therein, as to which such counsel
need express no opinion), when they were filed with the Commission or as
subsequently amended, complied as to form in all material respects with the
requirements of the Exchange Act and the rules and regulations of the Commission
thereunder;
(xiii) The
Registration Statement and the Prospectus and any further amendments and
supplements thereto made by the Company prior to such Time of Delivery (other
than the financial statements, pro forma and related schedules therein, as to
which such counsel need express no opinion) comply as to form in all material
respects with the requirements of the Act and the rules and regulations
thereunder; and such counsel does not know of any contracts or other agreements
of a character required to be incorporated by reference into the Prospectus or
required to be filed as an exhibit to the Registration Statement or required to
be described in the Registration Statement or Prospectus which are not filed or
incorporated by reference or described as required;
(xiv) The
Shares have been duly authorized and, when issued delivered and paid for in
accordance with this Agreement, will be validly issued, fully paid and
nonassessable; and the issuance and sale of the Shares is not subject to any
preemptive right under the laws of the state of New York or the certificate of
incorporation or bylaws of the Company;
(xv) Any
required filing of the Prospectus pursuant to Rule 424(b) has been made in the
manner and within the time period required by Rule 424(b);
(xvi) All
descriptions in the Prospectus of contracts and other documents to which the
Company or its subsidiaries are a party are accurate in all material respects;
to such counsel’s knowledge, there are no franchises, contracts, indentures,
mortgages, loan agreements, notes, leases or other instruments required to be
described or referred to in the Prospectus other than those described or
referred to therein or filed or incorporated by reference as exhibits thereto,
and the descriptions thereof or references thereto are correct in all material
respects; and
(xvii) The
information in the Company’s most recent Form 10-K under “Item 3. Legal
Proceedings,” to the extent that it constitutes matters of law, summaries of
legal matters, or legal proceedings, or legal conclusions, has been reviewed by
such counsel and is correct in all material respects. To such
counsel’s knowledge, there are no legal or governmental proceedings pending or
threatened against or affecting the Company or the Bank that are required to be
disclosed in the Registration Statement or the Prospectus, other than those
disclosed therein.
In
addition, although they do not assume any responsibility for the accuracy,
completeness or fairness of the statements contained in the Registration
Statement, the General Disclosure Package (as described below) or the
Prospectus, except for those referred to in the opinion in subsection (x) of
this section 7(c), they have no reason to believe that, (a) as of the date
hereof, the Registration Statement or any further amendment thereto made by the
Company prior to such Time of Delivery (other than the financial statements, pro
forma and related schedules therein, as to which such counsel need express no
opinion) contained an untrue statement of a material fact or omitted to state a
material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not
misleading, (b) as of its date, the General Disclosure Package contained an
untrue statement of a material fact or omitted to state a material fact
necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading or (c) that, as of its date, the Prospectus
or any further amendment or supplement thereto made by the Company prior to such
Time of Delivery (other than the financial statements, pro forma and related
schedules therein, as to which such counsel need express no opinion) contained
an untrue statement of a material fact or omitted to state a material fact
necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading or that, as of such Time of Delivery,
either the Registration Statement, General Disclosure Package or the Prospectus
or any further amendment or supplement thereto made by the Company prior to such
Time of Delivery (other than the financial statements, pro forma and related
schedules therein, as to which such counsel need express no opinion) contains an
untrue statement of a material fact or omits to state a material fact necessary
to make the statements therein, in the light of the circumstances under which
they were made, not misleading; and they do not know of any amendment to the
Registration Statement required to be filed;
(d) On
the date of the Prospectus at a time prior to the execution of this Agreement,
on the effective date of any post-effective amendment to the Registration
Statement filed subsequent to the date of this Agreement and also at each Time
of Delivery, Xxxxx Xxxxxxx LLP shall have furnished to you a letter or letters,
dated the respective dates of delivery thereof, in form and substance
satisfactory to you, containing statements and information of the type
ordinarily included in accountants “comfort letters” to underwriters with
respect to the financial statements of the Company and certain financial
information contained in the Prospectus;
(e) At
Closing Time, Xxxxx Xxxxxxx LLP shall have delivered a letter, dated as of the
Closing Time, to the effect that they reaffirm the statements made in the letter
furnished pursuant to subsection (d) of this Section, except that the
specified date referred to shall be a date not more than three business days
prior to the Effective Date;
(f) (i)
Neither the Company nor any of its subsidiaries shall have sustained since the
date of the latest audited financial statements included in the Prospectus any
loss or interference with its business from fire, explosion, flood or other
calamity, whether or not covered by insurance, or from any labor dispute or
court or governmental action, order or decree, otherwise than as set forth or
contemplated in the Prospectus, and (ii) since the respective dates as of which
information is given in the Prospectus there shall not have been any change in
the capital stock or long-term debt of the Company or any of its subsidiaries or
any change, or any development involving a prospective change, in or affecting
the general affairs, management, financial position, stockholders’ equity or
results of operations of the Company and its subsidiaries, otherwise than as set
forth or contemplated in the Prospectus, the effect of which, in any such case
described in clause (i) or (ii), is in the judgment of the Underwriter so
material and adverse as to make it impracticable or inadvisable to proceed with
the public offering or the delivery of the Shares being delivered at such Time
of Delivery on the terms and in the manner contemplated in the
Prospectus;
(g) On
or after the date hereof (i) no downgrading shall have occurred in the rating
accorded the Company’s debt securities by any “nationally recognized statistical
rating organization,” as that term is defined by the Commission for purposes of
Rule 436(g)(2) under the Act, and (ii) no such organization shall have publicly
announced that it has under surveillance or review, with possible negative
implications, its rating of any of the Company’s debt securities;
(h) On
or after the date hereof there shall not have occurred any of the following: (i)
a suspension or material limitation in trading in securities generally on the
New York Stock Exchange or on the Nasdaq Stock Market; (ii) a suspension or
material limitation in trading in the Company’s securities on the Nasdaq Stock
Market; (iii) a general moratorium on commercial banking activities declared by
either Federal or New York authorities or a material disruption in commercial
banking or securities settlement or clearance services in the United States;
(iv) the outbreak or escalation of hostilities involving the United States or
the declaration by the United States of a national emergency or war; or (v) the
occurrence of any other calamity or crisis or any change in financial, political
or economic conditions in the United States or elsewhere, including without
limitation, as a result of terrorist activities occurring after the date hereof,
if the effect of any such event specified in clause (iv) or (v), in the judgment
of the Underwriter makes it impracticable or inadvisable to proceed with the
public offering or the delivery of the Shares being delivered at such Time of
Delivery on the terms and in the manner contemplated in the
Prospectus;
(i) The
Shares to be sold at such Time of Delivery shall have been duly listed for
quotation on the Nasdaq Global Select Market;
(j) The
Company has obtained and delivered to the Underwriter executed copies of an
agreement from each officer and director and certain stockholders, in each case
as listed on Schedule I hereto of the Company, substantially in the
form of Exhibit
A;
(k) The
Company shall have complied with the provisions of Section 5(c) hereof with
respect to the furnishing of prospectuses on the New York Business Day next
succeeding the date of this Agreement; and
(l) The
Company shall have furnished or caused to be furnished to you at such Time of
Delivery certificates of officers of the Company satisfactory to you as to the
accuracy of the representations and warranties of the Company herein at and as
of such Time of Delivery, as to the performance by the Company of all of its
obligations hereunder to be performed at or prior to such Time of Delivery, as
to the matters set forth in subsections (a) and (e) of this Section and as to
such other matters as you may reasonably request.
If any
condition specified in this Section shall not have been fulfilled when and as
required to be fulfilled, this Agreement may be terminated by you by notice to
the Company at any time on or prior to the Time of Delivery. If the
sale of the Shares provided for herein is not consummated because any condition
set forth in this Section 7 is not satisfied, because of any termination
pursuant to Section 10(a) hereof, or because of any refusal, inability or
failure on the part of the Company to perform any agreement herein or comply
with any provision hereof, the Company will reimburse the Underwriter upon
demand for all documented out-of-pocket expenses (including reasonable fees and
disbursements of counsel up to $150,000) that shall have been incurred by the
Underwriter in connection with the proposed offering of the
Shares. In addition, such termination shall be subject to Section 6
hereof, and Sections 1, 8 and 9 hereof shall survive any such termination and
remain in full force and effect.
8.(a) The
Company and the Bank, jointly and severally, will indemnify and hold
harmless the Underwriter, each person, if any who controls the Underwriter,
within the meaning of Section 15 of the Act or Section 20 of the Exchange Act,
and its respective partners, directors, officers, employees and agents against
any losses, claims, damages or liabilities, joint or several, to which the
Underwriter may become subject, under the Act or otherwise, insofar as such
losses, claims, damages or liabilities (or actions in respect thereof) arise out
of or are based upon an untrue statement or alleged untrue statement of a
material fact contained in any Preliminary Prospectus, the Registration
Statement or the Prospectus, or any amendment or supplement thereto, or arise
out of or are based upon the omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements
therein not misleading, and will reimburse the Underwriter for any legal or
other expenses reasonably incurred by the Underwriter in connection with
investigating or defending any such action or claim as such expenses are
incurred; provided,
however, that the
Company and the Bank shall not be liable in any such case to the extent that any
such loss, claim, damage or liability arises out of or is based upon an untrue
statement or alleged untrue statement or omission or alleged omission made in
any Preliminary Prospectus, the Registration Statement or the Prospectus or any
such amendment or supplement in reliance upon and in conformity with written
information furnished to the Company by the Underwriter expressly for use
therein (provided that
the Company, the Bank and the Underwriter hereby acknowledge and agree that the
only information that the Underwriter has furnished to the Company specifically
for inclusion in the Registration Statement, any Preliminary Prospectus (or any
amendment or supplement thereto) are the share allocation, concession and
reallowance figures appearing in the Prospectus in the section entitled
“Underwriting”). Notwithstanding the foregoing, the indemnification
provided for in this paragraph (a) shall not apply to the extent such
indemnification by the Bank is found in a final judgment by a court of competent
jurisdiction to constitute a covered transaction under Section 23A of the
Federal Reserve Act.
(b) The
Underwriter will indemnify and hold harmless the Company against any losses,
claims, damages or liabilities to which the Company may become subject, under
the Act or otherwise, insofar as such losses, claims, damages or liabilities (or
actions in respect thereof) arise out of or are based upon an untrue statement
or alleged untrue statement of a material fact contained in any Preliminary
Prospectus, the Registration Statement or the Prospectus, or any amendment or
supplement thereto, or arise out of or are based upon the omission or alleged
omission to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading, in each case to the
extent, but only to the extent, that such untrue statement or alleged untrue
statement or omission or alleged omission was made in any Preliminary
Prospectus, the Registration Statement or the Prospectus or any such amendment
or supplement in reliance upon and in conformity with written information
furnished to the Company by the Underwriter expressly for use therein (provided
that the Company and the Underwriter hereby acknowledge and agree that the only
information that the Underwriter has furnished to the Company specifically for
inclusion in the Registration Statement, any Preliminary Prospectus (or any
amendment or supplement thereto) are the share allocation, concession and
reallowance figures appearing in the Prospectus in the section entitled
“Underwriting”); and will reimburse the Company for any legal or other expenses
reasonably incurred by the Company in connection with investigating or defending
any such action or claim as such expenses are incurred.
(c) Promptly
after receipt by an indemnified party under subsection (a) or (b) above of
notice of the commencement of any action, such indemnified party shall, if a
claim in respect thereof is to be made against the indemnifying party under such
subsection, notify the indemnifying party in writing of the commencement
thereof; but the omission so to notify the indemnifying party shall not relieve
it from any liability which it may have to any indemnified party otherwise than
under such subsection, but failure to so notify an indemnifying party shall not
relieve such indemnifying party from any liability hereunder to the extent it is
not materially prejudiced as a result thereof and in any event shall not relieve
it from any liability which it may have otherwise than on account of this
indemnity agreement. In case any such action shall be brought against
any indemnified party and it shall notify the indemnifying party of the
commencement thereof, the indemnifying party shall be entitled to participate
therein and, to the extent that it shall wish, jointly with any other
indemnifying party similarly notified, to assume the defense thereof, with
counsel satisfactory to such indemnified party (who shall not, except with the
consent of the indemnified party which consent shall not be unreasonably
withheld, be counsel to the indemnifying party) provided, however, if the
defendants in any such action include both the indemnified party and the
indemnifying party and the indemnified party shall have reasonably concluded
that a conflict may arise between the positions of the indemnifying party and
the indemnified party in conducting the defense of any such action or that there
may be legal defenses available to its and/or other indemnified parties which
are different from or additional to those available to the indemnifying party,
the indemnified party or parties shall have the right to select separate counsel
to assume such legal defenses and to otherwise participate in the defense of
such action on behalf of such indemnified party or parties, and, after notice
from the indemnifying party to such indemnified party of its election so to
assume the defense thereof, the indemnifying party shall not be liable to such
indemnified party under such subsection for any legal expenses of other counsel
or any other expenses, in each case subsequently incurred by such indemnified
party, in connection with the defense thereof other than reasonable costs of
investigation unless (i) the indemnified party shall have employed separate
counsel in accordance with the proviso to the preceding sentence (it being
understood, however, that the indemnifying party shall not be liable for the
expenses of more than one separate counsel (together with local counsel),
approved by the indemnifying party or (ii) the indemnifying party shall not have
employed counsel satisfactory to the indemnified party within a reasonable time
after notice of commencement of the action, in each of which cases the fees and
expenses of counsel shall be at the expense of the indemnifying
party. The indemnifying party under this Section 8 shall not be
liable for any settlement of any proceedings effected without its written
consent, but if settled with such consent or if there be a final judgment for
the plaintiff, the indemnifying party agrees to indemnify the indemnified party
against any loss, claim, damage, liability or expense by reason of such
settlement or judgment. Notwithstanding the foregoing sentence, if at
any time an indemnified party shall have requested an indemnifying party to
reimburse the indemnified party for fees and expenses of counsel as contemplated
by this Section 8(c), the indemnifying party agrees that it shall be liable for
any settlement of any proceeding effected without its written consent if (i)
such settlement is entered into more than 30 days after receipt by such
indemnifying party of the aforesaid request and (ii) such indemnifying party
shall not have reimbursed the indemnified party in accordance with such request
(other than those fees and expenses that are being contested in good faith)
prior to the date of such settlement. No indemnifying party shall,
without the written consent of the indemnified party, effect the settlement or
compromise of, or consent to the entry of any judgment with respect to, any
pending or threatened action or claim in respect of which indemnification or
contribution may be sought hereunder (whether or not the indemnified party is an
actual or potential party to such action or claim) unless such settlement,
compromise or judgment (i) includes an unconditional release of the indemnified
party from all liability arising out of such action or claim and (ii) does not
include a statement as to or an admission of fault, culpability or a failure to
act, by or on behalf of any indemnified party.
(d) If
the indemnification provided for in this Section 8 is unavailable to or
insufficient to hold harmless an indemnified party under subsection (a) or (b)
above in respect of any losses, claims, damages or liabilities (or actions in
respect thereof) referred to therein, then each indemnifying party shall
contribute to the amount paid or payable by such indemnified party as a result
of such losses, claims, damages or liabilities (or actions in respect thereof)
in such proportion as is appropriate to reflect the relative benefits received
by the Company on the one hand and the Underwriter on the other from the
offering of the Shares. If, however, the allocation provided by the
immediately preceding sentence is not permitted by applicable law or if the
indemnified party failed to give the notice required under subsection (c) above,
then each indemnifying party shall contribute to such amount paid or payable by
such indemnified party in such proportion as is appropriate to reflect not only
such relative benefits but also the relative fault of the Company on the one
hand and the Underwriter on the other in connection with the statements or
omissions which resulted in such losses, claims, damages or liabilities (or
actions in respect thereof), as well as any other relevant equitable
considerations. The relative benefits received by the Company on the
one hand and the Underwriter on the other shall be deemed to be in the same
proportion as the total net proceeds from the offering (before deducting
expenses) received by the Company bear to the total underwriting discounts and
commissions received by the Underwriter, in each case as set forth in the table
on the cover page of the Prospectus. The relative fault shall be
determined by reference to, among other things, whether the untrue or alleged
untrue statement of a material fact or the omission or alleged omission to state
a material fact relates to information supplied by the Company on the one hand
or the Underwriter on the other and the parties’ relative intent, knowledge,
access to information and opportunity to correct or prevent such statement or
omission. The Company, the Bank and the Underwriter agree that it
would not be just and equitable if contributions pursuant to this subsection (d)
were determined by pro
rata allocation or by any other method of allocation which does not take
account of the equitable considerations referred to above in this subsection
(d). The amount paid or payable by an indemnified party as a result
of the losses, claims, damages or liabilities (or actions in respect thereof)
referred to above in this subsection (d) shall be deemed to include any legal or
other expenses reasonably incurred by such indemnified party in connection with
investigating or defending any such action or claim. Notwithstanding
the provisions of this subsection (d), the Underwriter shall not be required to
contribute any amount in excess of the amount by which the total price at which
the Shares underwritten by it and distributed to the public were offered to the
public exceeds the amount of any damages which the Underwriter has otherwise
been required to pay by reason of any such untrue or alleged untrue statement or
omission or alleged omission. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Act) shall be
entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation. For purposes of this Section 8, each officer and
employee of the Underwriter and each person, if any, who controls the
Underwriter within the meaning of the Act and the Exchange Act shall have the
same rights to contribution as the Underwriter, and each director of the
Company, each officer of the Company who signed the Registration Statement, and
each person, if any, who controls the Company with the meaning of the Act and
the Exchange Act shall have the same rights to contribution as the
Company.
(e) The
obligations of the Company and the Bank under this Section 8 shall be in
addition to any liability which the Company or the Bank may otherwise have and
shall extend, upon the same terms and conditions, to each person, if any, who
controls the Underwriter within the meaning of the Act or who is an affiliate or
partner of the Underwriter; and the obligations of the Underwriter under this
Section 8 shall be in addition to any liability which the Underwriter may
otherwise have and shall extend, upon the same terms and conditions, to each
officer and director of the Company, and to each other person, if any, who
controls the Company within the meaning of the Act or who is an affiliate of the
Company.
9.The
respective indemnities, agreements, representations, warranties and other
statements of the Company and the Underwriter, as set forth in this Agreement or
made by or on behalf of them, respectively, pursuant to this Agreement, shall
remain in full force and effect, regardless of any investigation (or any
statement as to the results thereof) made by or on behalf of the Underwriter or
any controlling person of the Underwriter, or the Company, or any officer or
director or controlling person of the Company, and shall survive delivery of and
payment for the Shares.
10.(a)
The Underwriter may terminate this Agreement, by notice to the Company, at any
time on or prior to the Time of Delivery if, since the time of execution of this
Agreement or, in the case of (i) below, since the date of the most recent
balance sheets included in the Financial Statements, there has occurred: (i) any
Material Adverse Effect; or (ii) a suspension or material limitation in trading
in the Company’s securities on the Nasdaq Global Select Market; or (iii) a
general moratorium on commercial banking activities declared by either Federal
or New York authorities or a material disruption in commercial banking or
securities settlement or clearance services in the United States; or (iv) the
outbreak or escalation of hostilities involving the United States or the
declaration by the United States of a national emergency or war; or (v) the
occurrence of any other calamity or crisis or any change in financial, political
or economic conditions in the United States or elsewhere, including without
limitation, as a result of terrorist activities occurring after the date hereof,
if the effect of any such event specified in clause (iv) or (v), in the judgment
of the Underwriter makes it impracticable or inadvisable to proceed with the
public offering or the delivery of the Shares being delivered at such Time of
Delivery on the terms and in the manner contemplated in the
Prospectus.
(b) If
this Agreement is terminated pursuant to this Section 10, such termination shall
be without liability of any party to any other party except as provided in
Section 6 hereof and provided further that Sections 1, 8 and 9 hereof shall
survive such termination and remain in full force and effect.
11. All
statements, requests, notices and agreements hereunder shall be in writing, and
if to the Underwriter shall be delivered or sent by mail, telex or facsimile
transmission to 000 Xxxxx Xxxxxx, 0xx Xxxxx,
Xxx Xxxx, XX 00000, Attention: General Counsel, with a copy to Xxxxxxxxxx
Xxxxxxxx LLP, 000 00xx Xxxxxx,
X.X., Xxxxx 000, Xxxxxxxxxx, X.X. 00000, Attention: Xxxx X. Xxxxxxx; and if to
the Company shall be delivered or sent by mail or facsimile to Smithtown
Bancorp, Inc., 000 Xxxxx Xxxxxxx, Xxxxx 000, Xxxxxxxxx, Xxx Xxxx 00000,
Attention: Xxxxxxx X. Rock, Chairman, President and Chief Executive Officer,
with a copy to Xxxx Xxxxxx Xxxxxxxx & Xxxxxx, P.C., 0000 Xxxxxxxxx Xxxxxx,
X.X., Xxxxx 000, Xxxxxxxxxx, X.X. 00000, Attention: Xxxx X.
Xxxxxx. Any such statements, requests, notices or agreements shall
take effect upon receipt thereof.
12. This
Agreement shall be binding upon, and inure solely to the benefit of, the
Underwriter, the Company and, to the extent provided in Sections 8 and 9 hereof,
the officers and directors of the Company and each person who controls the
Company or the Underwriter, and their respective heirs, executors,
administrators, successors and assigns, and no other person shall acquire or
have any right under or by virtue of this Agreement. No purchaser of any of the
Shares from the Underwriter shall be deemed a successor or assign by reason
merely of such purchase.
13. Time
shall be of the essence of this Agreement. As used herein, the term
“business day” shall mean any day when the Commission’s office in Washington,
D.C. is open for business.
14. THIS
AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF
THE STATE OF NEW YORK, WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES OF SAID
STATE OTHER THAN SECTION 5-1401 OF THE NEW YORK GENERAL OBLIGATIONS
LAW.
THE
COMPANY, ON BEHALF OF ITSELF AND ITS SUBSIDIARIES, HEREBY IRREVOCABLY SUBMITS TO
THE EXCLUSIVE JURISDICTION OF THE FEDERAL AND NEW YORK STATE COURTS LOCATED IN
THE CITY OF NEW YORK IN CONNECTION WITH ANY SUIT, ACTION OR PROCEEDING RELATED
TO THIS AGREEMENT OR ANY OF THE MATTERS CONTEMPLATED HEREBY, IRREVOCABLY WAIVES
ANY DEFENSE OF LACK OF PERSONAL JURISDICTION AND IRREVOCABLY AGREES THAT ALL
CLAIMS IN RESPECT OF ANY SUIT, ACTION OR PROCEEDING MAY BE HEARD AND DETERMINED
IN ANY SUCH COURT. THE COMPANY, ON BEHALF OF ITSELF AND ITS
SUBSIDIARIES, IRREVOCABLY WAIVES, TO THE FULLEST EXTENT IT MAY EFFECTIVELY DO SO
UNDER APPLICABLE LAW, ANY OBJECTION WHICH IT MAY NOW OR HEREAFTER HAVE TO THE
LAYING OF VENUE OF ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN ANY SUCH COURT
AND ANY CLAIM THAT ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN ANY SUCH COURT
HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.
15. This
Agreement may be executed by any one or more of the parties hereto in any number
of counterparts, each of which shall be deemed to be an original, but all such
counterparts shall together constitute one and the same instrument.
16. No amendment or waiver of any provision of this
Agreement, nor any consent or approval to any departure therefrom, shall in any
event be effective unless the same shall be in writing and signed by the parties
hereto.
[Signatures on Next Page]
If the foregoing is in accordance with
your understanding, please sign and return to us four counterparts hereof, and
upon the acceptance hereof by you, this letter and such acceptance hereof shall
constitute a binding agreement between the Underwriter and the
Company.
Very
truly yours,
|
|
Smithtown
Bancorp, Inc.
|
|
By:
|
/s/Xxxxxxx X. Rock
|
Xxxxxxx
X. Rock
|
|
Chairman,
President and Chief Executive
Officer
|
Accepted
as of the date hereof:
SANDLER
X’XXXXX & PARTNERS, L.P.
By: Sandler
X’Xxxxx & Partners Corp.,
the
sole general partner
By:
/s/ Xxxxxx X.
Xxxxxxxx
|
Name:
Xxxxxx X. Xxxxxxxx
|
Title: Vice
President
|
EXHIBIT
A
___________________,
2009
Sandler
X’Xxxxx & Partners, L.P.
000 Xxxxx
Xxxxxx, 0xx
Xxxxx
Xxx Xxxx,
XX 00000
Re:
|
Proposed Public
Offering by Smithtown Bancorp,
Inc.
|
The
undersigned, an executive officer, director and/or stockholder of Smithtown
Bancorp, Inc., a New York corporation, or one of its significant subsidiaries
(the “Company”),
understands that Sandler X’Xxxxx & Partners, L.P. (the “Underwriter”),
proposes to enter into an Underwriting Agreement (the “Underwriting
Agreement”) with the Company providing for the public offering of shares
(the “Shares”)
of the Company’s common stock, $0.01 par value per share (the “Stock”). In
recognition of the benefit that such an offering will confer upon the
undersigned as an executive officer, director and/or stockholder of the Company,
and for other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the undersigned agrees with the Underwriter that,
during a period of 90 days from the date of the Underwriting Agreement, the
undersigned will not, without the prior written consent of the Underwriter,
directly or indirectly, (i) offer, pledge, sell, contract to sell, sell any
option or contract to purchase, purchase any option or contract to sell, grant
any option, right or warrant for the sale of, or otherwise dispose of or
transfer any shares of the Company’s Stock or any securities convertible into or
exchangeable or exercisable for Stock, whether now owned or hereafter acquired
by the undersigned or with respect to which the undersigned has or hereafter
acquires the power of disposition, or file any registration statement under the
Securities Act of 1933, as amended, with respect to any of the foregoing or (ii)
enter into any swap or any other agreement or any transaction that transfers, in
whole or in part, directly or indirectly, the economic consequence of ownership
of the Stock, whether any such swap or transaction is to be settled by delivery
of Stock or other securities, in cash or otherwise. If either (i)
during the period that begins on the date that is 15 calendar days plus three
(3) business days before the last day of the 90-day restricted period and ends
on the last day of the 90-day restricted period, the Company issues an earnings
release or material news or a material event relating to the Company occurs, or
(ii) prior to the expiration of the 90-day restricted period, the Company
announces that it will release earnings results during the 16-day period
beginning on the last day of the 90-day restricted period, the restrictions set
forth herein will continue to apply until the expiration of the date that is 15
calendar days plus three (3) business days after the date on which the earnings
release is issued or the material news or event related to the Company
occurs. The Company shall promptly notify the Underwriter of any
earnings releases, news or events that may give rise to an extension of the
initial restricted period.
Notwithstanding
the foregoing, the undersigned may transfer the undersigned’s shares of Stock
(i) as a bona fide gift
or gifts, provided that the donee or donees agree to be bound in writing by the
restrictions set forth herein, (ii) to any trust or family limited partnership
for the direct or indirect benefit of the undersigned or the immediate family of
the undersigned, provided that the trustee of the trust or general partner of
the family limited partnership, as the case may be, agrees to be bound by the
restrictions set forth herein, and provided further that any such transfer shall
not involve a disposition for value, (iii) pledged in a bona fide transaction
outstanding as of the date hereof to a lender to the undersigned, as disclosed
in writing to the Underwriter, (iv) pursuant to the exercise by the undersigned
of stock options that have been granted by the Company prior to, and are
outstanding as of, the date of the Underwriting Agreement, where the Stock
received upon any such exercise is held by the undersigned, individually or as
fiduciary, in accordance with the terms of this Lock-Up Agreement, (v) pursuant
to Rule 10b5-1 plans of the undersigned in effect as of the date of the
Underwriting Agreement, or (vi) with the prior written consent of the
Underwriter. For purposes of this Lock-Up Agreement, “immediate
family” shall mean any relationship by blood, marriage or adoption, not more
remote than first cousin.
The
undersigned also agrees and consents to the entry of stop transfer instructions
with the Company’s transfer agent and registrar against the transfer of the
undersigned’s Company Stock, except in compliance with this Lock-Up
Agreement. In furtherance of the foregoing, the Company and its
transfer agent are hereby authorized to decline to make any transfer of
securities if such transfer would constitute a violation or breach of this
Lock-Up Agreement.
The
undersigned represents and warrants that the undersigned has full power and
authority to enter into this Lock-Up Agreement. The undersigned
agrees that the provisions of this Lock-Up Agreement shall be binding also upon
the successors, assigns, heirs and personal representatives of the
undersigned.
The
undersigned understands that, if the Underwriting Agreement does not become
effective, or if the Underwriting Agreement (other than the provisions thereof
which survive termination) shall terminate or be terminated prior to payment for
and delivery of the Stock to be sold thereunder, the undersigned shall be
released from all obligations under this Lock-up
Agreement. Notwithstanding anything herein to the contrary, this
Lock-up Agreement shall automatically terminate and be of no further effect as
of 5 p.m. Eastern Time on ______________, 2009 if a closing for the offering of
the Shares has not yet occurred as of that time.
This
Lock-up Agreement shall be governed by and construed in accordance with the laws
of the State of New York.
Very
truly yours,
|
||
Signature:
|
||
Print
Name:
|